Recruiting Hereditary Angioedema Studies in Walnut Creek
About Hereditary Angioedema Clinical Trials in Walnut Creek
Hereditary angioedema (HAE) is a rare genetic condition causing recurrent episodes of severe swelling in various body parts. It is caused by deficiency or dysfunction of C1 inhibitor protein. Treatment includes on-demand therapy for attacks and prophylactic medications to prevent episodes.
There are currently 2 hereditary angioedema clinical trials recruiting participants in Walnut Creek, CA. These studies are seeking a combined 180 participants. Research is being sponsored by ADARx Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hereditary Angioedema Clinical Trials in Walnut Creek — FAQ
Are there hereditary angioedema clinical trials in Walnut Creek?
Yes, there are 2 hereditary angioedema clinical trials currently recruiting in Walnut Creek, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Walnut Creek?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Walnut Creek research site will contact you about next steps.
Are clinical trials in Walnut Creek free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Walnut Creek studies also compensate for your time and travel.
What hereditary angioedema treatments are being tested?
The 2 active trials in Walnut Creek are testing new therapies including novel drugs, biologics, and treatment approaches for hereditary angioedema.
Data updated October 17, 2026 from ClinicalTrials.gov